Alejandro García

8PUBLICATIONS
16CO-AUTHORS
Disease surveillanceMajor global burdens of diseaseGene and molecular therapyMedical bacteriologyMedical parasitology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 06, 2026
Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor-Based Therapy in Naïve Adults With HIV.

|Nov 14, 2025
Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.

Javier Martínez-Sanz, Alejandro G García-Ruiz de Morales, Juan Macías

|Nov 03, 2025
Two or Three? Clinical and Proteomic Perspectives on Dolutegravir/Lamivudine Versus Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV Treatment.

Claudio Díaz-García, Sergio Serrano-Villar, Alejandro G García-Ruiz de Morales

|Oct 28, 2025
When Fungal Prophylaxis Fails: A Rare Case of <i>Rhodotorula mucilaginosa</i> Fungemia with Suspected Abdominal Origin.

Elia Asensi-Díaz, Laura Barbero Del Olmo, Patricia Urrutia

|Mar 28, 2025
Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in Antiretroviral-therapy-naive Adults With HIV: A Multicenter Prospective Cohort Study.

Alejandro G García-Ruiz de Morales, Miguel Suárez Robles, María Jesús Pérez-Elías

|Mar 28, 2025
Real-world Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Comparison With Other Regimens in People With HIV Starting Therapy With AIDS-Defining Conditions: Results From the CoRIS Cohort-The ACTUAS II Study.

Ignacio Pérez-Valero, Diana Corona Mata, Angela Camacho Espejo

Pageof 2

Frequent Collaborators

5 joint publications

Javier Martínez-Sanz

4 joint publications

Santiago Moreno

2 joint publications

Antonio Rivero

2 joint publications

Juan Macías